OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Heart and Lung Transplantation is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	473
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	215
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	107
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	97
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	95
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	91
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	89
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	83
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	72
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	66
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	62
Early Onset Malignancy in the First-Year After Heart Transplantation	62
Older Donor Hearts for Heart Transplantation	60
WITHDRAWN	59
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	57
Comparative Analysis of Fontan Transplant Outcomes	56
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	55
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	55
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	55
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	53
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	51
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	50
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	48
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	47
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	47

Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	46
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	45
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	43
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	42
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	42
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	42
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	41
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	41
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	40
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	40
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	37
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	37